. Structural resistance of WT TbSADH(green), TbSADH-1(red) and TbSADH-2(blue) to elevated temperatures was determined as thermal denaturation in phosphate buffer (50 mM, pH 7.4). 
Methods

Docking acetophenone (1a) into WT TbSADH
The X-ray structure 1 of TbSADH was used as the basis for docking calculations. The models of WT TbSADH was prepared as in a previous study. 2 Substrate acetophenone (1a) was prepared for docking using ChemDraw. Docking to the WT TbSADH was performed using autodock vina. Ten docking poses were requested and a constraint was applied such that only the docking poses in which the substrate coordinates to the active site zinc ion were saved.
PCR based methods for library construction of TbSADH
Libraries were constructed using Over-lap PCR and megaprimer approach with KOD Hot Start sec) × 28 cycles, 68 °C 10 min. The PCR products were analyzed on agarose gel by electrophoresis and purified using a Qiagen PCR purification kit. 2 µL NEB CutSmart™ Buffer and 2 µL Dpn I were added in 50 µL PCR reaction mixture and the digestion was carried out at 37 °C for 7 h. After Dpn I digestion, the PCR products 1.5 µL were directly transformed into electro-competent E. coli BL21(DE3) to create the final library for Quick Quality Control (QQC) 3 and screening.
Primer design and library creation of TbSADH
The previous constructed TbSADH single site saturation mutagenesis libraries at positions C37, S39, A85, W110, Y267, L294 and C295 in our lab were used for screening in this experiment. Other libraries were constructed as described below. Primer design and library construction depend upon the particular amino acid chosen, and in the case of TbSADH involves six single sites saturation Table S10 . The PCR products were digested by Dpn I and transformed into electro-competent E. coliBL21 (DE3) to create the library for screening.
Screening procedures
Colonies were picked and transferred into deep-well plates containing 300 μL LB medium with 50 ug/mL kanamycin and cultured overnight at 37 °C with shaking. An aliquot of 120 μL was transferred to glycerol stock plate and stored at −80 °C. Then, 800 μL TB medium with 0.2 mM IPTG and 50 μg/mL kanamycin was added directly to the culture plate for 8 h at 30 °C with shaking for protein expression. The cell pellets were harvested, then washed with 400μL of 50 mM, pH 7.4 potassium phosphate buffer and centrifuged for 10 min 4000 rpm at 4 °C. The cell pellets were resuspended in 400 μL of the same buffer (adding 5mM DTT, 10μM ZnCl 2 ) with 6 U DNase I and 1 mg/mL lysozyme for breaking the cell at 30 °C for 1 h with shaking. The crude lysate was centrifuged for 30 min 4000 rpm at 4 °C. A quantity of 20 μL of supernatant was transferred into new microliter-plates, and the activity was detected using the activity assay shown in below. Then the relative activity was obtained after comparing with the activity of WT TbSADH.
Protein expression and purification
E. coli BL21 (DE3) cells carrying the recombinant plasmid were cultivated in 5 mL LB medium containing kanamycin (50 ug/mL) overnight at 37°C. The overnight culture was inoculated into 500 mL of TB medium containing kanamycin (50 ug/mL) and grown at 37°C. The culture was induced by addition of isopropyl β-D-1-thiogalactopyranoside (IPTG) with a final concentration of 0.2 mM when OD 600 reached 0.6, and then allowed to grow for additional 12 h at 25°C. After centrifugation at 6000g for 15min at 4 °C, the bacterial pellet was washed with phosphate buffer (50 mM, pH 7.4), and resuspended in a phosphate buffer (20 mM, pH 7.4) containing 0.5 M of NaCl and 20 mM of imidazole. The cells were lysed by sonication and the supernatant was collected by centrifugation at 10000g for 60 min at 4 °C. Protein purification was performed using an AKTA Purifier 10 system with UNICORN 5 software (GE Healthcare). The WT and mutants were purified using affinity chromatography with a HisTrapTM FF crude column (GE, USA). The column was pre-equilibrated with 50 mL of equilibrium buffer (20 mM phosphate buffer, 0.5 M NaCl, 20 mM imidazole, pH 7.4). The sample (30 mL) was loaded with a flow rate of 2.0 mL/min. After washing with 50 mL of the equilibrium buffer, the bounded target protein was washed with 10−500 mM imidazole solution containing 500 mM NaCl and 20 mM potassium phosphate (pH 7.4). The target protein fraction was collected and desalted through a HiPrep 26/10 desalting column (GE Healthcare) against 20 mM phosphate buffer containing 5mM DTT, 10μM ZnCl 2 and 100 mM NaCl (pH 7.4). Protein concentration was measured using the Bradford method.
Activity assay
Enzyme activity was determined in a 0.2 mL volume of phosphate buffer (20 mM, pH 7.4) containing substrate (10 mM), NADPH (0.5 mM), 5mM DTT, 10μM ZnCl 2 and 20 uL enzyme. The substrate was dissolved in acetonitrile, which did not exceed 5% of the total volume. The reaction was initiated by the addition of the enzyme, and monitored for 1.2 min with SPECTRAMAX M5 (Molecular Devices, USA) at 30°C. The activity was determined by measuring NADPH oxidation from the decrease in absorbance at 340 nm using a molar absorption coefficient of 6.22 mM −1 cm −1 .
One unit of enzyme activity was defined as the amount of enzyme catalyzing the conversion of 1 umol NADPH per minute.
Determination of kinetic parameters
The kinetic parameters were obtained by measuring the initial velocities of the enzymic reaction 
Determination of thermostability by circular dichroism (CD)
CD spectra were recorded using Jasco J-810 spectropolarimeter (Jasco, Tokyo, Japan) equipped with the Peltier cell holder. Thermal unfolding of tested enzymes was followed by monitoring the ellipticity at 222 nm over the temperature range from 30 to 110ºC with a resolution of 0.1ºC and heating rate of 2ºC min -1 . Recorded thermal denaturation curves were fitted to sigmoidal curves using Origin 6.1 software. The melting temperature (T m ), the temperature at which half of the enzyme is in an unfolded state, was evaluated as the midpoint of the normalized thermal transition. A 1mL mixture of 200mM (500mM, 1M or 2M) acetophenone (1a), 0.1mM NADP + , 5mM DTT, 10μM ZnCl 2 , 300uL 2-propanol (500uL 2-propanol for 500mM, 1M and 2M acetophenone) and recombinant expression whole cells of TbSADH-1 or TbSADH-2 (OD 600 =50) in PBS buffer solution (50mM, pH 7.4) was stirred at 30°C. Then 0.1mL reaction product were extracted with ethyl ether (1 mL) at 4 and 20h, respectively. 400ul iso-propanol were added in the reaction system at 20h for pushing the reaction toward reduction. Then 0.1mL reaction product were extracted with ethyl ether (1 mL) at 36h.
Substrate 1b reduction catalyzed by WT TbSADH, and variants TbSADH-1 and TbSADH-2.
A 1mL mixture of 50mM 1b, 0.1mM NADP + , 5mM DTT, 10μM ZnCl 2 , 150uL 2-propanol (15%) and 0.2 mg purified WT TbSADH (TbSADH-1 or TbSADH-2) in PBS buffer solution (50mM, pH 7.4) was stirred at 30°C. Then 0.1mL reaction product were extracted with ethyl ether (1 mL) at 1, 3 and 20h, respectively.
Substrate 1c-d reduction catalyzed by WT TbSADH, variants ADH-1 and ADH-2.
A mixture of 10 mM substrate 1c-d, 0.1mM NADP + , 5mM DTT, 10μM ZnCl 2 , 150uL 2-propanol and recombined expression whole cells of WT TbSADH, ADH-1 or ADH-2 (OD 600 =30) in 1.0 mL PBS buffer solution (50mM, pH 7.4) was stirred at 30°C and then extracted with ethyl ether (1 mL) at 20h.
Molecular dynamics (MD) simulations.
MD simulations in explicit water were performed using AMBER 16 package 4 and starting from the PDB structure: 1YKF. 1 The A85G/I86A variant was generated using the mutagenesis tool included in PyMOL (http://www.pymol.org). Parameters for substrate 1a for the MD simulations were generated within the antechamber module of AMBER 16 using the general AMBER force field (GAFF), 5 with partial charges set to fit the electrostatic potential generated at the B3LYP/6-31G(d) level by the restrained electrostatic potential (RESP) model. 6 The charges were calculated according to the Merz-Singh-Kollman scheme 7, 8 using Gaussian 09. 9 Amino acid protonation states were predicted using the H++ server (http://biophysics.cs.vt.edu/H++). 10 We have used the bonded model for Zn metal center, the residues of the first coordination sphere and either the substrate or a water molecule (apo state) bound. 11 In particular we used the Seminario approach 12 to obtain the metal parameters needed for the simulation as implemented in Prof. Ryde program. 13 The optimization, frequencies and charge calculations to obtain the parameters was done at the B3LYP/6-31G(d) level using Gaussian 09. 7 The parameters for NAD(P)H were extracted from previous studies by Prof.
Ryde. 14, 15 The wild-type enzyme (PDB: 1YKF) and variant were solvated in a pre-equilibrated truncated cuboid box with a 10-Å buffer of TIP3P 16 water molecules using the AMBER16 leap module, resulting in the addition of ca. 9,000 solvent molecules. The system was neutralized by addition of explicit counterions (Na + and Cl − ). All calculations were done using a modification of the ff99SB force field (ff94SB). 17 A two-stage geometry optimization approach was performed. The first stage minimizes the positions of solvent molecules and ions imposing positional restraints on solute by a harmonic potential with a force constant of 500 kcal mol −1 Å −2 , and the second stage is an unrestrained minimization of all the atoms in the simulation cell. The systems are gently heated using six 50-ps steps, incrementing the temperature 50 K each step (0-300 K, 30ºC and 0-315 K, 45ºC) under constant volume and periodic boundary conditions. Water molecules were treated with the SHAKE algorithm such that the angle between the hydrogen atoms is kept fixed. Long-range electrostatic effects were modeled using the particle-mesh-Ewald method. 18 An 8-Å cutoff was applied to Lennard-Jones and electrostatic interactions. Harmonic restraints of 10 kcal/mol were applied to the solute, and the Langevin equilibration scheme was used to control and equalize the temperature. The time step was kept at 1 fs during the heating stages, allowing potential inhomogeneities to self-adjust. Each system was then equilibrated without restrains for 2 ns with a 2-fs timestep at a constant pressure of 1 atm and temperature of 300 K. After the systems were equilibrated in the NPT ensemble, 5 independent two hundred nanosecond MD simulations were performed under the NVT ensemble and periodic-boundary conditions at 30 and 45ºC in the substrate-bound and apo states. Therefore, an accumulated simulation time of 1 microsecond has been obtained for each variant (WT and A85G/I86A) at each temperature (30 and 45ºC) in both apo and substrate-bound states.
Supplementary movies of the MD simulations
Representative frames from two independent MD simulations for: the WT enzyme in the apo state at 30ºC (WT_30.mp4) and at 45ºC (WT_45.mp4); A85G/I86A variant in the apo state at 30ºC (mutant_30.mp4) and at 45ºC (mutant_45.mp4).
Active site volume changes along one representative MD simulation for: the WT enzyme in the apo state at 30ºC (volume_WT_30.mp4) and at 45ºC (volume_WT_45.mp4); the A85G/I86A variant in the apo state at 30ºC (volume_mutant_30.mp4), and at 45ºC (volume_mutant_45.mp4).
Schemes, Tables and Figures
Scheme S1. Prelog and anti-Prelog selectivity for model ketone reductions catalyzed by TbSADH. Table S1 . Screening results of single site saturation mutagenesis at positions C37, S39, I49, A85, I86, L107, W110, T154, Y267, C283, M285, L294 and C295 towards acetophenone (1a).
a: no positive hits were detected.
Library
Positive hits mutation Relative activity
LG-85-B10 A85G 1300%
LG-86-C6 I86C 1400%
LG-86-F6 I86E 900%
I86NNK
LG-86-H11 I86A 1500%
L107NNK ND
LG-110-B7 W110L 400%
LG-110-G7 W110I 450%
W110NNK
LG- 110-F8  W110E  650%   T154NNK  ND   Y267NNK  ND   C283NNK LG-283-E2 C283V 500%
LG-285-A10 M285V 400% M285NNK
LG-285-H6 M285L 300%
LG-294-H7 L294T 400% L294NNK
LG-294-F12 L294V 350%
C295NNK ND Table S2 . The code used for the construction of library A. Table S3 . Screening results of library A towards acetophenone (1a). Table S7 . Reduction of compound 1b (50mM) using purified WT TbSADH and best variants at 30°C. 
